Cephalon Submits NUVIGIL Supplemental New Drug Application For The Treatment Of Excessive Sleepiness Associated With Jet Lag Disorder
July 1st, 2009 Posted in Medical Information, Sleep / Sleep Disorders / Insomnia
Similar Posts
- Cephalon Announces That FDA Grants Priority Review Of Its Supplemental New Drug Application For NUVIGIL As A Treatment For Excessive Sleepiness
- Cephalon Announces Positive Results From A Phase Three Study Of NUVIGIL In Jet Lag Disorder
- NUVIGIL Is Available For The Treatment Of Excessive Sleepiness Associated With Treated Obstructive Sleep Apnea, Shift Work Disorder And Narcolepsy
- NUVIGIL Jet Lag Disorder Data Presented At The SLEEP 2009 23rd Annual Meeting Of The Associated Professional Sleep Societies
- GSK And Xenoport Announce Submission Of New Drug Application Requesting FDA Approval Of Solzira™ For Restless Legs Syndrome